Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Ads

You May Also Like

Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets

Summit Therapeutics plc  (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ...

Roche Purchases Shares in Tender Offer for FMI

Basel, 31 July 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, ...